These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37975398)

  • 21. Lipoprotein-associated phospholipase A2 in coronary heart disease: Review and meta-analysis.
    Li D; Zhao L; Yu J; Zhang W; Du R; Liu X; Liu Y; Chen Y; Zeng R; Cao Y; Zeng Z; Zhao Z; Wu J
    Clin Chim Acta; 2017 Feb; 465():22-29. PubMed ID: 27956130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Sarno MJ; Bettencourt R; Wolfert RL; Barrett-Connor E
    J Am Coll Cardiol; 2008 Mar; 51(9):913-9. PubMed ID: 18308160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between smoking and serum lipoprotein-associated phospholipase A2 level in overweight and obese men.
    Zhou H; Zhao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 48(2):191-197. PubMed ID: 36999465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of sLOX-1 and Lp-PLA2 can predict the prognosis of acute cerebral infarction with a high specificity.
    Yan P; Cao J; Zhou Y; Zhou X; Sun Z; Zhu X
    Physiol Rep; 2022 Jan; 10(1):e15160. PubMed ID: 35005850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated Lipoprotein-Associated Phospholipase A2 is Valuable in Prediction of Coronary Slow Flow in Non-ST-Segment Elevation Myocardial Infarction Patients.
    Liang Q; Lei X; Huang X; Fan L; Yu H
    Curr Probl Cardiol; 2021 Mar; 46(3):100596. PubMed ID: 32444159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostic value of combined detection of different indicators for type 2 diabetes mellitus combined with atherosclerotic disease].
    Jiang WW; Niu JD; Qi MJ; Song YW; Dang YQ; Yang PQ; Yang J; Liu YM
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(31):2448-2453. PubMed ID: 34399558
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease.
    Sofogianni A; Alkagiet S; Tziomalos K
    Curr Pharm Des; 2018; 24(3):291-296. PubMed ID: 29332572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between Levels of Serum Lipoprotein-Associated Phospholipase A2 and Soluble Suppression of Tumorigenicity 2 and Condition of Acute Heart Failure Patients and Their Predictive Value for Prognosis.
    Zhang J; Wang L; Zhao Z; Li L; Xia Y
    J Healthc Eng; 2021; 2021():1525190. PubMed ID: 34956555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Prognostic Value of Lipoprotein-Associated Phospholipase A
    Yang L; Wang H; Zhang Y; Han T; Wang W
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):822-827. PubMed ID: 29121808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between lipoprotein-associated phospholipase A
    Zhou F; Liu Y; Shi H; Huang Q; Zhou J
    Neurol Sci; 2018 Sep; 39(9):1591-1596. PubMed ID: 29938341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationships between biological novel biomarkers Lp-PLA
    Chen Y; Wang S; Li J; Fu Y; Chen P; Liu X; Zhang J; Sun L; Zhang R; Li X; Liu L
    J Diabetes; 2024 Jul; 16(7):e13574. PubMed ID: 38924255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between the D166E polymorphism of the lipoprotein associated phospholipase A2 and risk of myocardial infarction.
    Zhang MM; Zhang CG; Yang CJ; Zhao P; Li YL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3960-3966. PubMed ID: 31115024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients.
    Corsetti JP; Rainwater DL; Moss AJ; Zareba W; Sparks CE
    Clin Chem; 2006 Jul; 52(7):1331-8. PubMed ID: 16709622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
    Zhang H; Gao Y; Wu D; Zhang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein-Associated Phospholipase A2 has Comparable Ability as Anthropometric Indices to Discriminate Cardiovascular Disease Risk: A Cross-Sectional Study.
    Adejumo EN; Adefoluke JD; Nwobi NL; Okafor CJ; Lokpo SY
    West Afr J Med; 2023 Sep; 40(9):902-908. PubMed ID: 37761388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress.
    Koenig W; Twardella D; Brenner H; Rothenbacher D
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1586-93. PubMed ID: 16627803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic and prognostic performance of Lp-PLA2 in acute ischemic stroke.
    Li X; Xu L; Xu Z
    Med Clin (Barc); 2021 May; 156(9):437-443. PubMed ID: 33483146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy.
    Zhai Y; Cao X; Liu S; Shen Y
    Ann Med; 2023; 55(2):2230446. PubMed ID: 37566692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
    Cai A; Li G; Chen J; Li X; Li L; Zhou Y
    BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.